{
    "nctId": "NCT00676793",
    "briefTitle": "A Study of the Effect of Polyphenon E (Green Tea Extract) on Breast Cancer Progression",
    "officialTitle": "Phase II Clinical Trial to Determine if Polyphenon E Inhibits c-Met Signaling and Activation of Pathways Contributing to Breast Cancer Progression",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NA",
    "primaryPurpose": "BASIC_SCIENCE",
    "enrollmentCount": 32,
    "primaryOutcomeMeasure": "Change in Serum VEGF in Breast Cancer",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Definitive biopsy demonstrating primary breast cancer\n* Residual breast cancer requiring additional surgical resection\n* Stage I, II or III disease\n* Patient has ability to give signed informed consent\n* Normal hepatic and renal function (creatinine\\<1.5, transaminases \\<1.5 times upper limit of normal).\n* ECOG Performance status of 0 or 1.\n* Age \u2265 21 years and less than 75\n\nExclusion Criteria:\n\n* Prior hormonal or surgical therapy for breast cancer\n* Abnormal liver function test\n* Liver or kidney problems that would interfere with metabolism of study drug\n* Any condition that would hamper informed consent or ability to comply with study protocol\n* Participation in another research study in the last three months\n* Known malignancy at any site other than breast\n* Recent consumption of green tea (5 or more cups per day, within one week prior to biopsy)\n* Allergy or intolerance to any component of green tea\n* Inability or refusal to comply with definitive surgical therapy",
    "sex": "FEMALE",
    "minimumAge": "21 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}